Yost SE - Search Results

1

Combination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancer.

Yuan Y, Wen W, Yost SE, Xing Q, Yan J, Han ES, Mortimer J, Yim JH. Yuan Y, et al. Among authors: yost se. Sci Rep. 2019 May 17;9(1):7509. doi: 10.1038/s41598-019-43429-7. Sci Rep. 2019. PMID: 31101835 Free PMC article.

2

Genomic mutation-driven metastatic breast cancer therapy: a single center experience.

Yuan Y, Yost SE, Yim J, Yuan YC, Solomon NM, Mambetsariev I, Pal S, Frankel P, Salgia R, Neuhausen SL, Mortimer J. Yuan Y, et al. Among authors: yost se. Oncotarget. 2017 Apr 18;8(16):26414-26423. doi: 10.18632/oncotarget.14476. Oncotarget. 2017. PMID: 28061482 Free PMC article.

3

Association of Pre-Chemotherapy Peripheral Blood Pro-Inflammatory and Coagulation Factors with Physical Function in Women with Breast Cancer.

Yuan Y, Vora N, Sun CL, Li D, Smith D, Mortimer J, Luu TH, Somlo G, Waisman J, Chao J, Katheria V, Synold T, Tran V, Mi S, Feng T, Levi A, Arsenyan A, Choi J, Zavala L, Yost S, Hurria A. Yuan Y, et al. Oncologist. 2017 Oct;22(10):1189-1196. doi: 10.1634/theoncologist.2016-0391. Epub 2017 May 30. Oncologist. 2017. PMID: 28559409 Free PMC article.

4

Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer.

Yuan Y, Vora N, Sun CL, Li D, Soto-Perez-de-Celis E, Mortimer J, Luu TH, Somlo G, Waisman J, Smith D, Chao J, Katheria V, Synold T, Tran V, Mi S, Levi A, Arsenyan A, Choi J, Zavala L, Yost S, Hurria A. Yuan Y, et al. Breast Cancer Res. 2017 Aug 29;19(1):101. doi: 10.1186/s13058-017-0895-5. Breast Cancer Res. 2017. PMID: 28851415 Free PMC article.

5

Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience.

Yuan Y, Yost SE, Yim J, Yuan YC, Solomon NM, Mambetsariev I, Pal S, Frankel P, Salgia R, Neuhausen SL, Mortimer J. Yuan Y, et al. Among authors: yost se. Oncotarget. 2017 Sep 22;8(37):62817. doi: 10.18632/oncotarget.20632. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977992 Free PMC article.

6

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer.

Zhao ZM, Yost SE, Hutchinson KE, Li SM, Yuan YC, Noorbakhsh J, Liu Z, Warden C, Johnson RM, Wu X, Chuang JH, Yuan Y. Zhao ZM, et al. Among authors: yost se. BMC Cancer. 2019 Jan 21;19(1):96. doi: 10.1186/s12885-019-5290-4. BMC Cancer. 2019. PMID: 30665374 Free PMC article.

7

Differential gene expression and AKT targeting in triple negative breast cancer.

Lin FM, Yost SE, Wen W, Frankel PH, Schmolze D, Chu PG, Yuan YC, Liu Z, Yim J, Chen Z, Yuan Y. Lin FM, et al. Among authors: yost se. Oncotarget. 2019 Jul 9;10(43):4356-4368. doi: 10.18632/oncotarget.27026. eCollection 2019 Jul 9. Oncotarget. 2019. PMID: 31320990 Free PMC article.

8

Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients.

Egelston CA, Avalos C, Tu TY, Rosario A, Wang R, Solomon S, Srinivasan G, Nelson MS, Huang Y, Lim MH, Simons DL, He TF, Yim JH, Kruper L, Mortimer J, Yost S, Guo W, Ruel C, Frankel PH, Yuan Y, Lee PP. Egelston CA, et al. JCI Insight. 2019 Oct 3;4(19):e130000. doi: 10.1172/jci.insight.130000. JCI Insight. 2019. PMID: 31465302 Free PMC article.

9

Eribulin Synergistically Increases Anti-Tumor Activity of an mTOR Inhibitor by Inhibiting pAKT/pS6K/pS6 in Triple Negative Breast Cancer.

Wen W, Marcinkowski E, Luyimbazi D, Luu T, Xing Q, Yan J, Wang Y, Wu J, Guo Y, Tully D, Han ES, Yost SE, Yuan Y, Yim JH. Wen W, et al. Among authors: yost se. Cells. 2019 Aug 30;8(9):1010. doi: 10.3390/cells8091010. Cells. 2019. PMID: 31480338 Free PMC article.

10

Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes.

McQuerry JA, Jenkins DF, Yost SE, Zhang Y, Schmolze D, Johnson WE, Yuan Y, Bild AH. McQuerry JA, et al. Among authors: yost se. BMC Cancer. 2019 Sep 5;19(1):881. doi: 10.1186/s12885-019-6052-z. BMC Cancer. 2019. PMID: 31488082 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters